AGREEMENT OPENS UP $1.3 BILLION MARKET FOR EMEFCY
Written on the 10 October 2016
EMEFCY (ASX: EMC) has signed a deployment and distribution partnership for its Membrane Aerated Biofilm Reactor (MABR) wastewater treatment technology with Beijing Sinorichen Environmental Protection Corporation.
"Emefcy is investing substantial resources and starting to make important inroads in penetrating the rural wastewater treatment market in China," he says.
The MABR modules will initially be produced at Emefcy's manufacturing facility in Israel, but the company of seeking licence approvals to establish manufacturing facilities in Jiangsu Province and the first manufacturing line in China is expected to be in place by the second quarter of 2017.
The first Sinorichen installed MABR-based system is scheduled to be commissioned during the fourth quarter of 2016 and provisional certification is expected by the third quarter for 2017.